Difficulties in developing active-site-directed protein tyrosine phosphatase (PTP) inhibitors have led to the perception that PTPs are “undruggable”, highlighting the need for new means to target pharmaceutically important PTPs allosterically. Recently, we characterized an allosteric-inhibition site on the PTP domain of Src-homology-2-domain-containing PTP 2 (SHP2), a key anticancer drug target. The central feature of SHP2’s allosteric site is a nonconserved cysteine residue (C333) that can potentially be labeled with electrophilic compounds for selective SHP2 inhibition. Here, we describe the first directed discovery effort for C333-targeted allosteric SHP2 inhibitors. By screening a previously reported library of reversible, covalent inhibitors, we identified a lead compound, which was modified to yield an irreversible inhibitor (12), that inhibits SHP2 allosterically and selectively through interaction with C333. These findings provide a novel paradigm for allosteric-inhibitor discovery on SHP2, one that may help to circumvent the challenges inherent in targeting SHP2’s active site.
Diabetic retinopathy is one of the leading causes of blindness in the world with the incidence of disease ever-increasing worldwide. The vitreous humor represents an extensive and complex interactive arena for cytokines in the diabetic eye. In recent decades, there has been significant progress in understanding this environment and its implications in disease pathophysiology. In this review, we investigate the vitreous ecosystem in diabetic retinopathy at the molecular level. Areas of concentration include: the current level of knowledge of growth factors, cytokine and chemokine mediators, and lipid-derived metabolites in the vitreous. We discuss the molecular patho-mechanisms of diabetic retinopathy based upon current vitreous research.
26 April 2016 in World Journal of Emergency Surgery
Cigarette smoking causes about one of every five deaths in the U.S. each year. In 2013 the prevalence of smoking in our institution’s trauma population was 26.7 %, well above the national adult average of 18.1 % according to the CDC website. As a quality improvement project we implemented a multimodality smoking cessation program in a high-risk trauma population. All smokers with independent mental capacity admitted to our level I trauma center from 6/1/2014 until 3/31/2015 were counseled by a physician on the benefits of smoking cessation. Those who wished to quit smoking were given further counseling by a pulmonary rehabilitation nurse and offered nicotine replacement therapy (e.g. nicotine patch). A planned 30 day or later follow-up was performed to ascertain the primary endpoint of the total number of patients who quit smoking, with a secondary endpoint of reduction in the frequency of smoking, defined as at least a half pack per day reduction from their pre-intervention state. During the 9 month study period, 1066 trauma patients were admitted with 241 (22.6 %) identified as smokers. A total of 31 patients with a mean Injury Severity Score (ISS) of 14.2 (range 1–38), mean age of 47.6 (21–71) and mean years of smoking of 27.1 (2–55), wished to stop smoking. Seven of the 31 patients, (22.5 %, 95 % confidence interval [CI] of 10–41 %) achieved self-reported smoking cessation at or beyond 30 days post discharge. An additional eight patients (25.8 %, 95 % CI 12–45 %) reported significant reduction in smoking. Trauma patients represent a high risk smoking population. The implementation of a smoking cessation program led to a smoking cessation rate of 22.5 % and smoking reduction in 25.8 % of all identified smokers who participated in the program. This is a relatively simple, inexpensive intervention with potentially far reaching and beneficial long-term health implications. A larger, multi-center prospective study appears warranted. LEVEL OF EVIDENCE: Therapeutic Study, Level V evidence.
Purpose: To report a rare case of congenital bilateral vitreous cysts associated with a unilateral cataract in a pediatric patient and describe the clinical, surgical, and histopathologic findings. Methods: A single pediatric case was reviewed. Results: A 5-year-old boy with no significant past medical history presented after a failed vision screening, with symptoms of light sensitivity and frequent rubbing of the left eye. Examination revealed bilateral vitreous cysts and a unilateral cataract. The cyst in the left eye with the cataract was large and obscured the macula. The patient underwent pars plana vitrectomy and lensectomy. Postoperatively, optic nerve head and macular swelling with retinal dragging were observed, possibly owing to the mechanical effect of the cyst. Intraoperatively, the cyst was found to have attachments to the temporal pars plana, with adjacent chorioretinal scars in both eyes. Histopathologic analysis demonstrated cuboidal and spindle cells consistent with a diagnosis of a primary nonpigmented ciliary body epithelial cyst. Evaluation for acquired etiologies was unremarkable. Conclusions: This case highlights a rare presentation of congenital vitreous cysts with associated cataract and retinal structural changes. Histopathologic findings supported a primary nonpigmented ciliary body epithelial origin after exclusion of acquired causes.
Purpose: The purpose of this study was to evaluate Descemet stripping automated endothelial keratoplasty (DSAEK) graft survival and outcomes in eyes with preexisting glaucoma, and secondarily to assess the effect of donor graft characteristics on DSAEK survival and outcomes. Methods: DSAEK cases between 2013 and 2023 were retrospectively reviewed. Eyes were stratified based on glaucoma status: no prior glaucoma, medically managed glaucoma, and surgically managed glaucoma. Graft survival was calculated using Kaplan–Meier analysis. Patient and graft characteristics were evaluated by multivariate analysis. Results: 395 eyes were reviewed: 260 with no prior glaucoma, 42 with medically managed glaucoma, and 93 with prior glaucoma surgery [trabeculectomy, glaucoma drainage device (GDD), or both]. At 5 years, eyes with history of trabeculectomy or both trabeculectomy and GDD had statistically lower graft survival than controls (OR: 2.22; P < 0.001; OR: 2.00; P = 0.007). No difference was seen for GDD alone (OR: 1.02; P = 0.517) or medically managed glaucoma (OR: 0.98; P = 0.789). Donor age, ocular cooling time, graft thickness, death to preservation time, and endothelial count had no significant impact on 5-year survival rates in any subgroup. Conclusions: The presence of a trabeculectomy was associated with shorter term DSAEK graft survival, whereas the presence of GDD alone was not. Donor graft characteristics did not affect long-term graft survival. This study suggests that the type of preexisting glaucoma surgery may influence DSAEK survival.